Advertisement

Related Videos

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Advertisement

Advertisement




Mar
09
Today In Oncology
Partial Gland Removal May Be an Option for Many Men With Prostate Cancer
How the Cancer Moonshot Is Making a Difference for Patients Here and Across the World
Greater Plant Based Oil Lower Butter Intake Could Improve Risk of Cancer Related Mortality
Breast Cancer Mortality Rates May Have Stopped Declining
SGLT2 Inhibitors Could Help Protect Against Heart Failure in Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo